Impact of Mutation Density and Heterogeneity on Papillary Thyroid Cancer Clinical Features and Remission Probability-Reference-Cited by-同舟云学术

Impact of Mutation Density and Heterogeneity on Papillary Thyroid Cancer Clinical Features and Remission Probability

Published:2019-02 Issue:2 Volume:29 Page:237-251
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Colombo Carla¹²,Muzza Marina¹²³,Proverbio Maria Carla²,Tosi Delfina⁴⁵,Soranna Davide⁶,Pesenti Chiara²⁷,Rossi Stefania⁴,Cirello Valentina¹,De Leo Simone¹²,Fusco Nicola⁷⁸,Miozzo Monica²⁷,Bulfamante Gaetano⁴⁵,Vicentini Leonardo⁹,Ferrero Stefano⁷⁸,Zambon Antonella¹⁰,Tabano Silvia²⁷,Fugazzola Laura¹²

Affiliation:

1. Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy.

2. Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.

3. Endocrine Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.

4. Unit of Pathology, ASST Santi Paolo e Carlo, Milan, Italy.

5. Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.

6. IRCCS Istituto Auxologico Italiano, Milan, Italy.

7. Division of Pathology, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.

8. Department of Biomedical, Surgical, and Dental Sciences, Università degli Studi di Milano, Milan, Italy.

9. Endocrine Surgery Unit, IRCCS Istituto Auxologico Italiano, Milan, Italy.

10. Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2018.0339

Reference35 articles.

1. Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis

2. Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance

3. Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer

4. BRAF mutation is not predictive of long‐term outcome in papillary thyroid carcinoma

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TERT promoter mutations and additional molecular alterations in thyroid fine-needle aspiration specimens: A multi-institutional study with histopathologic follow-up;American Journal of Clinical Pathology;2024-09-09

2. Case report & review: Bilateral NIFTP harboring concomitant HRAS and KRAS mutation: Report of an unusual case and literature review;Molecular Carcinogenesis;2024-09-04

3. Extra-nuclear TERT counteracts oxidative stress and promotes progression in papillary thyroid carcinoma;Translational Research;2024-09

4. Radiofrequency ablation is an effective treatment for Bethesda III thyroid nodules without genetic alterations;European Thyroid Journal;2024-04-24

5. Association of BRAF V600E Mutant Allele Proportion with the Dissemination Stage of Papillary Thyroid Cancer;Biomedicines;2024-02-21